Early-Onset Alzheimer Disease.
Mendez MF.
Neurol Clin. 2017 May;35(2):263-281. doi: 10.1016/j.ncl.2017.01.005.
New insights into atypical Alzheimer's disease in the era of biomarkers.
Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME.
Lancet Neurol. 2021 Mar;20(3):222-234. doi: 10.1016/S1474-4422(20)30440-3.
Early-onset Alzheimer Disease and Its Variants.
Mendez MF.
Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.
Early-onset familial Alzheimer's disease (EOFAD).
Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S.
Can J Neurol Sci. 2012 Jul;39(4):436-45. doi: 10.1017/s0317167100013949.
Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY, Zhang Y.
Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289.
Biomarkers in Alzheimer's disease.
Rajendran K, Krishnan UM.
Clin Chim Acta. 2024 Aug 15;562:119857. doi: 10.1016/j.cca.2024.119857. Epub 2024 Jul 8.
Early- and late-onset Alzheimer disease: Are they the same entity?
Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate MR, Arbizu J, Riverol M.
Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3.
Atypical Alzheimer Disease Variants.
Polsinelli AJ, Apostolova LG.
Continuum (Minneap Minn). 2022 Jun 1;28(3):676-701. doi: 10.1212/CON.0000000000001082.
The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
Sirin S, Nigdelioglu Dolanbay S, Aslim B.
J Neural Transm (Vienna). 2022 Jul;129(7):847-859. doi: 10.1007/s00702-022-02499-0. Epub 2022 Apr 16.
Alzheimer's disease prevention: from risk factors to early intervention.
Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL.
Alzheimers Res Ther. 2017 Sep 12;9(1):71. doi: 10.1186/s13195-017-0297-z.
